Contact the ACC Registration and Housing Center

  • (888) 322-2878
    (toll-free)
  • (847) 996-5822 (International)
  • M-F, 9:00 a.m. - 6:00 p.m. ET
  • acc@experient-inc.com
  • Accreditation

    ACC.18 Statement of Educational Need and Purpose

    Despite tremendous advances in recent years, cardiovascular disease (CVD) remains the leading cause of death throughout the world. While many areas within CVD require further research to improve outcomes, other areas have established best-practice patterns, but struggle with implementation. Members of the cardiovascular team are critical in leading the way to address these issues. Education is key to keeping clinicians up-to-date with the latest science and advances in CVD that will ultimately lead to improvements in cardiovascular disease. ACC.18 will provide clinicians the opportunity for a comprehensive review of evidence-based practices as well as exposure to state-of-the-art updates, innovative techniques, and novel research on the diagnosis and management of cardiovascular disease.

      Educational Program Goals
      Educational Program Goals
    • To provide a stimulating environment for information sharing, presentation of research, networking and collaboration with a goal of improving cardiovascular disease management for all patients
    • To facilitate translation of cardiovascular science to all members of the heart team leading to high-quality, patient-centered care
    • To allow for examination and discussion of important contributions and controversies in cardiovascular care
    • To integrate traditional and novel educational techniques to create an interactive and informative learning environment
      Credit Information
      Credit Information
      Physicians
      Physicians

    The American College of Cardiology Foundation (ACCF) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The ACCF designates this live activity for a maximum of 28.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      Nurses
      Nurses

    The American College of Cardiology Foundation (ACCF) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

    The ACCF designates this educational activity for a maximum of 28.5 continuing nursing education contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

      Pharmacists
      Pharmacists

    In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and ACC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Click here for a list of the ACPE certified sessions >>>

      European Board for Accreditation in Cardiology (EBAC) External CME Credit
      European Board for Accreditation in Cardiology (EBAC) External CME Credit

    The live activity “ACC.18” is accredited by the European Board for Accreditation in Cardiology (EBAC) for 18 hours of External CME credits. Each participant should claim only those hours of credit that have actually been spent in the educational activity. The Accreditation Council for Continuing Medical Education (ACCME) and the European Board for Accreditation in Cardiology (EBAC) have recognized each other’s accreditation systems as substantially equivalent.

      Maintenance of Certification
      Maintenance of Certification

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 28.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    Click here for a list of MOC sessions >>>

      Learning Objectives
      Learning Objectives
      Acute and Stable Ischemic Heart Disease
      Acute and Stable Ischemic Heart Disease

    As a result of participating in the Acute and Stable Ischemic Heart Disease Pathway sessions, learners will have an improved or reinforced ability to...

    1. Compare and contrast different STEMI and NSTEMI systems of care and logistical processes for managing complex patients with ACS
    2. Formulate a differential diagnosis and management strategy for athletes presenting with ischemic heart disease
    3. Scrutinize the methodology of recent ACS clinical trials and existing gaps in current guidelines to determine the implications and generalizability of findings
    4. Evaluate the evidence and different perspectives underlying current controversies in ACS management and ACS Guidelines, including international and other societal guidelines
    5. Describe the management of complications seen in ischemic coronary heart diseases
    6. Integrate the expertise of a multi-professional and multidisciplinary Heart Team in ischemic heart disease
    7. Incorporate cardiac rehab clinical advances and health care payment reform into practice
    8. Discuss where sex differences exist in cardiovascular medicine and how to tailor management accordingly
    9. Assess and appropriately manage patients with cardiogenic shock or in need of critical care
    10. Detect and manage patients with angina refractory to conventional strategies and chest pain assessed in clinic, chest pain/clinical decision units, and inpatient
    11. Risk-stratify and tailor the selection of medical management vs. revascularization for individual patients with ischemia, including anticoagulation therapies
    12. Identify the diagnosis and management of atypical ischemic heart disease presentations, including endothelial dysfunction, microvascular dysfunction, spontaneous coronary artery dissection, and ischemia without obstructive coronary artery disease
      Arrhythmias and Clinical EP
      Arrhythmias and Clinical EP

    As a result of participating in the Arrhythmias and Clinical EP Pathway sessions, learners will have an improved or reinforced ability to...

    1. Apply recent evidence and current guideline recommendations to the management of arrhythmias
    2. Integrate emerging evidence and options for prevention, detection, risk assessment, rhythm and rate management, and stroke prevention into the care of patients with atrial fibrillation
    3. Identify patients and patient populations who can benefit from currently available and investigational device-based therapies
    4. Recognize and interpret salient ECG patterns and integrate into clinical decision-making
    5. Evaluate athletes with heart disease for return to play based on current guidelines.
    6. Recognize patients at risk for adverse cardiovascular outcomes due to ventricular arrhythmia; identify candidates for medical or ablation therapy
      Congenital Heart Disease
      Congenital Heart Disease

    As a result of participating in the Congenital Heart Disease (CHD) Pathway sessions, learners will have an improved or reinforced ability to...

    1. Recognize the patient with CHD who should be managed or periodically assessed at a specialized CHD Care Center and which approach (adult, pediatric, and team-based) is appropriate. Formulate plans for transition from pediatric to adult care.
    2. Recognize common issues in the management of patients with CHD, including aortic involvement, cardiogenic shock, cardiomyopathies, and single ventricle
    3. Identify novel strategies in imaging to effectively evaluate CHD
    4. Compare surgical versus interventional approaches to CHD
    5. Describe the role of emerging transcatheter therapies and surgical techniques in the management of CHD
    6. Establish high-functioning teams and participate in local and national quality improvement initiatives to identify critical gaps as well as potential strategies for better care delivery
    7. Explain the structure and applications of multicenter registries, such as IMPACT, to improve patient care in CHD
    8. Utilize the latest understanding of exercise in cardiovascular disease with a focus on high risk populations.
    9. Incorporate recent advances and research into cardiology practice for congenital heart disease
      Heart Failure and Cardiomyopathy
      Heart Failure and Cardiomyopathy

    As a result of participating in the Heart Failure and Cardiomyopathies Pathway sessions, learners will have an improved or reinforced ability to...

    1. Integrate contemporary concepts in the pathophysiology of cardiovascular disease into the diagnosis, evaluation, and management across a broad spectrum of patients with heart failure and cardiomyopathy
    2. Offer practical guidance on diet, exercise, social support, and heart failure self-management that is appropriately tailored to diverse patient populations
    3. Recognize the implications of sleep apnea, diabetes, chronic kidney disease, oncologic therapies, pregnancy, and additional comorbidities on the epidemiology and management of heart failure
    4. Evaluate the role and indications for ICDs, CRTs, hemodynamic sensors, and other cardiac devices for heart failure management
    5. Identify patients with heart failure or cardiogenic shock that are appropriate candidates for specific pharmacotherapies, mechanical circulatory support, cardiac transplantation, and/or palliative care
    6. Analyze the evidence on new and established pharmacotherapies, devices, and novel therapies for heart failure management
    7. Participate in high-functioning teams and refine system processes to improve care quality and outcomes for patients with heart failure
    8. Recognize future approaches to heart failure and cardiomyopathy that are being investigated/researched currently
    9. Develop insight into the complexities of end-of-life care and care of the frail, elderly heart failure patient.
    10. Identify the impact of health care reform on the care of heart failure patients
      Noninvasive Imaging
      Noninvasive Imaging

    As a result of participating in the Noninvasive Imaging Pathway sessions, learners will have an improved or reinforced ability to...

    1. Apply current echocardiography guidelines for the assessment of valvular, myocardial, pericardial and complex congenital and structural heart diseases
    2. Compare the strengths and limitations of non-invasive and invasive imaging modalities in the peri-procedural management of structural heart disease interventions
    3. Identify both current and emerging roles of stress echocardiography for evaluating ischemia, viability, diastolic function and valvular heart diseases
    4. Evaluate the clinical role and value of non-invasive imaging modalities for the cardiovascular assessment of patients treated with chemotherapy
    5. Assess imaging and hemodynamic findings in patients with hypertrophic cardiomyopathy that influence prognosis and management
    6. Evaluate recent innovations in advanced imaging techniques and their potential applications
    7. Compare the relative strengths, limitations, risks and costs of non-invasive imaging tests for patients with new-onset heart failure, acute and stable chest pain, amyloidosis, hypertrophic cardiomyopathy and for the evaluation of myocardial viability to guide revascularization
    8. Utilize findings from noninvasive imaging to clarify the etiology and guide the management of patients with heart failure or cardiomyopathy
    9. Recognize the prognostic implications of cardiac CT findings and their appropriate impact on patient management
    10. Compare the strengths, limitations and appropriate use of imaging modalities for the evaluation of the right ventricle
      Invasive CV Angiography and Intervention
      Invasive CV Angiography and Intervention

    As a result of participating in the Invasive CV Angiography and Intervention Pathway sessions, learners will have an improved or reinforced ability to...

    1. Monitor and address gaps in quality, appropriateness, reimbursement, and safety in the cardiac catheterization and endovascular labs and participate in meaningful public reporting for revascularization procedures
    2. Determine an appropriate adjunctive and long-term antithrombotic regimen for diverse patients with acute coronary syndrome or undergoing a revascularization procedure, and address issues with antiplatelet regimens in patients at high risk for bleeding
    3. Interpret and integrate findings from adjunctive coronary and endovascular assessment into clinical decision-making
    4. Decide whether and how to revascularize patients who are high-risk or have complex coronary artery disease
    5. Evaluate the evidence from clinical trials describing outcomes, recent advances, and expanded applications of transcatheter aortic valve replacement (TAVR)
    6. Describe key tactics for preventing and managing interventional complications
    7. Appropriately incorporate new and state-of-the-art structural heart and endovascular technologies and techniques into patient care
    8. Work effectively as part of a comprehensive care team to manage patients before, during, and after an interventional procedure
    9. Apply findings from diagnostic imaging to plan treatment, guide intervention, and gauge procedural outcomes
      Prevention
      Prevention

    As a result of participating in the Prevention Pathway sessions, learners will have an improved or reinforced ability to...

    1. Integrate evidence-based diagnostic testing, and shared decision-making into ASCVD risk assessment and risk factor management
    2. Apply current evidence base to determine thresholds for hypertension treatment, establish therapeutic goals, and implement team-based processes to achieve timely blood pressure control and in complex cases
    3. Recognize the implications of diabetes on cardiovascular disease and treatment outcomes and tailor management accordingly
    4. Evaluate often conflicting recommendations as well as the underlying evidence on dyslipidemia and ASCVD, including dietary and medication recommendations for prevention of disease
    5. Discuss recent clinical trials assessing new therapeutics for prevention and management of ASCVD
    6. Integrate best practices with regards to lifestyle and dietary recommendations to prevent or manage ASCVD and related diseases, such as diabetes
    7. Consider unique factors in prevention and management of ASCVD for vulnerable populations
      Pulmonary Hypertension and Venous Thromboembolic Disease
      Pulmonary Hypertension and Venous Thromboembolic Disease

    As a result of participating in the Pulmonary Hypertension and Venous Thromboembolic Disease Pathway sessions, learners will have an improved or reinforced ability to...

    1. Evaluate the diagnostic and therapeutic options for patients with pulmonary hypertension and the multiple potential etiologies of pulmonary hypertension
    2. Identify innovative translational discoveries and the potential for personalized medicine in PAH
    3. Apply current practice and innovative research to the cardiology practice for patient population with VTE
    4. Compare and contrast opposing approaches and controversies in the cardiology practice of VTE
    5. Determine diagnostic criteria within the spectrum of Pulmonary Hypertension (PH), decisions regarding therapies, and best methods to determine clinical response to treatment
      Valvular Heart Disease
      Valvular Heart Disease

    As a result of participating in Valvular Heart Disease (VHD) Pathway sessions, learners will have an improved or reinforced ability to...

    1. Apply recent updates to guidelines and recommend best practices for valvular care to clinical practice
    2. Describe the evidence and controversies associated with recent changes to the classification framework and treatment thresholds outlined in the VHD Guidelines Update
    3. Recognize how the mechanism, natural history, diagnosis and treatment options of patients with right- and left-sided valve disease continue to evolve and affect patient care algorithms
    4. Assess the role of advanced echo techniques, stress imaging, CT and CMR in characterizing native and prosthetic valvular disease and guiding management
    5. Recognize the importance of the heart team approach to treatment of patients with complex VHD whose care may not be well-described by current VHD guidelines
    6. Incorporate the evidence on contemporary surgical, percutaneous, and device-based treatment options into clinical decision-making for patients with VHD
    7. Compare strategies in assessment, diagnosis and treatment of special populations with valvular heart disease
      Vascular Medicine
      Vascular Medicine

    As a result of participating in Vascular Medicine Pathway sessions, learners will have an improved or reinforced ability to...

    1. Evaluate the evidence associated with current controversies in the management of pulmonary embolism and deep venous thrombosis
    2. Incorporate recent clinical trial findings and evidence-based guideline recommendations into the treatment of patients with vascular disease
    3. Assess common vascular medicine complaints and synthesize the history, examination, and appropriate testing to diagnosis “can’t miss” vascular medicine disorders
    4. Utilize team-based approach to provide maximally effective Vascular Medicine care
    5. Recognize and effectively treat common vascular and thrombotic complications of cancer and cancer-directed therapy
    6. Identify the influence of health information technology’s impact in the area of vascular medicine on optimizing vascular patient outcomes

    Advertisement

    ACC Logo
    ACC.18 on Social Media:
          
    2018 American College of Cardiology Foundation. Visit ACC.org
    Terms and Conditions Registered User Agreement Advertising and Sponsorship Policy Privacy Policy Contact Us